Prestigious Life Sciences Platform and Awards Launch in Tokyo to Celebrate Breakthrough Innovation
TOKYO, Sept. 11, 2026 /PRNewswire/ — The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced that it will host the first Prix Galien Japan Forum, followed by an Awards Ceremony in the evening, on Thursday, February 25, 2027, at the Hotel New Otani, in Tokyo.
The inaugural event marks the first Prix Galien in Japan, recognizing the most transformative breakthroughs in pharmaceutical, biotechnology, medical technology, rare and orphan diseases, startup, and digital health solutions, while honoring the companies, researchers, and innovators whose work has altered the course of human health.
“My heartfelt congratulations on the launch of the Prix Galien in Japan,” said Nobel Laureate Prof. Tasuku Honjo. “This award recognizes that the cumulative efforts of long-term research generate value for society and carry forward the progress and integrity of science into the future.”
Awards will be presented across the following categories: “Best Pharmaceutical Product,” “Best Biotechnology Product,” “Best Product for Rare/Orphan Diseases,” “Best Medical Technology,” “Best Digital Health Solution,” and “Best Startup.” Winners are selected by the Prix Galien Japan Awards Committees, comprising leading biomedical scientists and industry executives from Japan and around the world.
“Through international collaboration, innovation in medicine advances hope and transforms lives worldwide,” commented Prof. Shinya Yamanaka, Nobel Laureate. “The launch of the Prix Galien Japan embodies this spirit.”
The Prix Galien Japan Awards Ceremony will precede a series of Prix Galien events in Asia, such as the Prix Galien India in New Delhi on March 18, 2027. The events celebrate the foremost leaders, innovators, and decision-makers in life sciences.
Event Details
Date: Thursday, February 25, 2027
Location: Hotel New Otani Tokyo
More details on the Prix Galien Japan Forum agenda to follow.
Sponsorship and attendance opportunities are available. For more information, please visit
www.galienfoundation.org or contact: contact@galienfoundation.org
About The Galien Foundation
The Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation to improve human health. Its vision is to serve as a catalyst for the development of the next generation of treatments and technologies that will transform medical practice and save lives. Established in Paris in 1970 by Roland Mehl in honor of Galen, the father of medical science and modern pharmacology, the Prix Galien is widely regarded as the equivalent of the Nobel Prize in biopharmaceutical research.
Today, the Prix Galien operates through 18 chapters spanning more than 75 countries across Africa, the Americas, Asia, and Europe. Expansion is currently underway in China, Singapore, and Australia.
In 2025, the Foundation launched the inaugural Prix Galien Bridges Forum and Awards Ceremony at the Nobel Forum in Stockholm, spanning Northern and Southern Europe, Israel, and the Middle East, and the first-ever Patient Summit for Prix Galien USA, reinforcing its commitment to science without borders.
The Nobel Prize and the Prix Galien share a common birthplace in Paris, where Alfred Nobel signed his last will and testament in 1895. However, while the Nobel Prize in Physiology or Medicine recognizes up to three individuals for specific discoveries, the Prix Galien honors the collaborative spirit and multidisciplinary progress that define modern biopharmaceutical innovation.
For more information, visit www.galienfoundation.org.
Follow the Foundation on social media:
https://www.facebook.com/GalienFoundation/https://twitter.com/GalienFdn
https://www.linkedin.com/company/the-galien-foundation/
Media Contact:
Kara Bradley
Finn Partners
Kara.Bradley@finnpartners.com646-213-7243
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/the-galien-foundation-announces-inaugural-prix-galien-japan-forum–awards-ceremony-302873770.html
SOURCE The Galien Foundation
